Sgmt Stock Analysis Sagimet Biosciences Inc Series A Biotech Up 1.53 Pct At 5.32 20260403 1 Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution XTNT Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain SPB Q1 2026 Earnings Earnings Beat Estimates Amidst Solid Operational Execution TPG Q1 2026 Earnings EPS Beats Estimates by 14 Stock Edges Lower DocGo Inc DCGO Q1 2026 Earnings EPS Misses as Revenue Data Remains Limited MAIA Biotechnology Q1 2026 Earnings NarrowerThanExpected Loss Highlights Continued Pipeline Progress TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress LEGN Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Advances on Operational Progress BMEA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline IRM Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Stock Slips PZZA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment MPB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines